HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brooks, S. R. Articles by Carter, R. H. Search for Related Content PubMed PubMed Citation Articles by Brooks, S. R. Articles by Carter, R. H.

Binding of Cytoplasmic Proteins to the CD19 Intracellular Domain Is High Affinity, Competitive, and Multimeric¹

Stephen R. Brooks^2,*, Perry M. Kirkham^2,, Larry Freeberg and Robert H. Carter^3,*,,

Departments of ^* Microbiology, Pharmacology, and Medicine, University of Alabama, Birmingham, AL 35294; and Birmingham Veterans Affairs Medical Center, Birmingham, AL 35233

CD19 is required for the development of B1 and marginal zone B cells, for Ab responses, and for B cell memory. CD19 immunoprecipitates contain a complex of cytoplasmic proteins, including Lyn, Vav, phospholipase C2 (PLC2), Grb2, and the p85 subunit of phosphatidylinositol 3-kinase. Which of these bind directly to CD19 and the strengths of the interactions are unknown. These issues are important in understanding the signaling functions of CD19, which are crucial for normal B cell physiology. Using purified, recombinant proteins, we now show that each of these signaling proteins contains at least one Src homology 2 (SH2) domain that interacts directly with the phosphorylated CD19 cytoplasmic domain. The affinities of binding of the SH2 domains of Vav, p85, and Grb2 to CD19 are each in the nanomolar range by surface plasmon resonance (Biacore) analysis. Binding of Lyn and PLC2 do not fit 1:1 modeling. However, analyses of binding data (Lyn) and competition experiments (PLC2) suggest that these bind with comparable affinity. Competition experiments demonstrate that SH2 domains whose binding is dependent on the same CD19 tyrosine(s) compete for binding, but these SH2 domains do not impede binding of different SH2 domains to other CD19 tyrosines. We conclude that binding to the CD19 cytoplasmic domain is multimeric, high affinity, and competitive. The high affinity of the interactions also suggests that tyrosines that were nonessential in vivo are nevertheless functional. A preliminary structural model suggests that CD19 forms a signaling complex containing multiple cytoplasmic proteins in close proximity to each other and to the plasma membrane.

Related articles in The JI:

IN THIS ISSUE

The JI 2004 172: 7227-7228. [Full Text]  

This article has been cited by other articles:

				E. Arana, N. E. Harwood, and F. D. Batista Regulation of integrin activation through the B-cell receptor J. Cell Sci., July 15, 2008; 121(14): 2279 - 2286. [Abstract] [Full Text] [PDF]

				M. Weber, B. Treanor, D. Depoil, H. Shinohara, N. E. Harwood, M. Hikida, T. Kurosaki, and F. D. Batista Phospholipase C-{gamma}2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen J. Exp. Med., April 14, 2008; 205(4): 853 - 868. [Abstract] [Full Text] [PDF]

				M. C. van Zelm, I. Reisli, M. van der Burg, D. Castano, C. J.M. van Noesel, M. J.D. van Tol, C. Woellner, B. Grimbacher, P. J. Patino, J. J.M. van Dongen, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med., May 4, 2006; 354(18): 1901 - 1912. [Abstract] [Full Text] [PDF]